ATS 2024 Final Program

Click on the session title to view the speakers

309

TUESDAY • MAY 21

609 Evaluation of the Accuracy of Combined Robotic Assisted Bronchoscopy (RAB) and Cone Beam Computed Tomography (CBCT) 610 Comparison of Procedural Safety and Diagnostic Yield Between Robotic Bronchoscopy Platforms 611 The Battle of Two Robotic-assisted Bronchoscopy Platforms: A Comparative Cohort Study 612 Detection of Clinically Significant Pneumothorax Using Lung Ultrasound Following Cryobiopsy for Peripheral Pulmonary Lesions 613 Trends in Station-Based Lymph Node Sampling for Early-Stage Non-Small Cell Lung Cancer From 2009 to 2019 614 How Many Passes Are Enough in EBUS-TBNA Procedures for Diagnostic Yield of Next Generation Sequencing in Non-small Cell Lung Cancer? 615 Performance of Computer-assisted Detection Algorithms on Unstained Slides During Rose Procedures 616 Neoadjuvant Soft Tissue Ablation Utilizing Aliya™ Pulsed Electric Fields With Systemic Therapy in Early-stage Resectable Non-small Cell Lung Cancer (NSCLC)- VIGOR Study 617 Improvement in Benign Surgical Resection Rate and Later Stage Thoracotomies After Interventional Pulmonology Management of a VA Thoracic Oncology Program 618 Outcomes of Therapeutic Bronchoscopy in Malignant Airway Obstruction Causing Acute Respiratory Failure 619 Inert Brachytherapy Seed Placement by Robotic Bronchoscopy With Cone-beam Computed Tomography Guidance to Simulate Early-stage Lung Cancer Treatment: A Human Cadaveric Feasibility Pilot 620 Distribution and Cytotoxicity of Cisplatin After Intratumoral Injection in Lung Tumors 621 Immune Tone of T Lymphocytes Within Tumor-draining Lymph Nodes of Advanced-stage Non-small Cell Lung Cancer Is Associated With Early Mortality 622 Efficacy and Adverse Events of Osimertinib Correlate With Blood Concentration of Osimertinib and Its Active Metabolites, AZ5104 and AZ7550

623 Transcriptomic Signatures in Elderly Patients With Early-stage NSCLC Are Associated With Disease Recurrence 624 Modeling Treatment Effect of Onvansertib, A Polo Like 1 (PLK1) Inhibitor, in Small Cell Lung Cancer Using Radiomic Analysis 625 High Blood Eosinophil Counts Predict Poor Surgical Outcomes in Early Stage Lung Cancer

ATS 2024 Conference Program • San Diego, CA